Systematic review and meta-analysis of the efficacy and safety of alendronate and zoledronate for the treatment of postmenopausal osteoporosis - PubMed

Affiliations

• PMID: 24063695
• DOI: 10.3109/09513590.2013.813468

Free article

Review

Systematic review and meta-analysis of the efficacy and safety of alendronate and zoledronate for the treatment of postmenopausal osteoporosis

Ana Julissa Serrano et al. Gynecol Endocrinol. 2013 Dec.

Free article

Abstract

The aim of this meta-analysis was to evaluate the efficacy and safety of two bisphosphonates (alendronate and zoledronate) in the treatment of postmenopausal osteoporosis. The incidence of fractures was considered as primary endpoint. Only randomized trials with a follow-up period of 1 year or more were included in this systematic review and meta-analysis. We excluded studies that included patients with secondary osteoporosis especially in relation to therapy with corticosteroids or other drugs or diseases known to affect bone mineral density. Studies published as subgroup analysis, extension studies, economic evaluations, and comparisons with active control were excluded. The methodological quality of controlled clinical trials that met these inclusion criteria was evaluated. No studies were excluded from analysis due to lack of quality. The risk ratio of hip, vertebral and wrist fractures for alendronate were 0.61 [95% confidence interval (CI) 0.40-0.93], 0.54 (95% CI 0.44-0.66) and 0.65 (95% CI 0.33-1.25), respectively. Zoledronate risk ratio was 0.62 (95% CI 0.46-0.82) and 0.38 (95% CI 0.22-0.67) for hip and vertebral fractures, respectively.

Similar articles

• Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.

  Iwamoto J, Takeda T, Sato Y. Iwamoto J, et al. Curr Med Res Opin. 2006 May;22(5):919-28. doi: 10.1185/030079906X100276. Curr Med Res Opin. 2006. PMID: 16709313 Review.

• Randomized trial comparing efficacies of zoledronate and alendronate for improving bone mineral density and inhibiting bone remodelling in women with post-menopausal osteoporosis.

  Tan W, Sun J, Zhou L, Li Y, Wu X. Tan W, et al. J Clin Pharm Ther. 2016 Oct;41(5):519-23. doi: 10.1111/jcpt.12429. Epub 2016 Jul 21. J Clin Pharm Ther. 2016. PMID: 27440710 Clinical Trial.

• The effects of teriparatide and bisphosphonates on new fractures in postmenopausal women with osteoporosis: A protocol for systematic review and meta-analysis.

  Ouyang Y, Chen S, Wan T, Zheng G, Sun G. Ouyang Y, et al. Medicine (Baltimore). 2021 Feb 19;100(7):e24839. doi: 10.1097/MD.0000000000024839. Medicine (Baltimore). 2021. PMID: 33607854 Free PMC article.

• CLINICAL EVALUATION OF COST EFFICACY OF DRUGS FOR TREATMENT OF OSTEOPOROSIS: A META-ANALYSIS.

  Albert SG, Reddy S. Albert SG, et al. Endocr Pract. 2017 Jul;23(7):841-856. doi: 10.4158/EP161678.RA. Epub 2017 Apr 27. Endocr Pract. 2017. PMID: 28448754 Review.

Cited by

• Inflammatory eye reactions with bisphosphonates and other osteoporosis medications: what are the risks?

  Clark EM, Durup D. Clark EM, et al. Ther Adv Musculoskelet Dis. 2015 Feb;7(1):11-6. doi: 10.1177/1759720X14566424. Ther Adv Musculoskelet Dis. 2015. PMID: 25650170 Free PMC article. Review.

• Efficacy and safety of bisphosphonates in management of low bone density in inflammatory bowel disease: A meta-analysis.

  Yao L, Wang H, Dong W, Liu Z, Mao H. Yao L, et al. Medicine (Baltimore). 2017 Jan;96(3):e5861. doi: 10.1097/MD.0000000000005861. Medicine (Baltimore). 2017. PMID: 28099343 Free PMC article.

• Comparison of Bone Mineral Density in Lumbar Spine and Fracture Rate among Eight Drugs in Treatments of Osteoporosis in Men: A Network Meta-Analysis.

  Chen LX, Zhou ZR, Li YL, Ning GZ, Zhang TS, Zhang D, Feng SQ. Chen LX, et al. PLoS One. 2015 May 26;10(5):e0128032. doi: 10.1371/journal.pone.0128032. eCollection 2015. PLoS One. 2015. PMID: 26010450 Free PMC article.

• Bisphosphonate's Effect on Tongue Mucosa: An Experimental Electron Microscopy Study.

  Papamitsou T, Morsi-Yeroyannis A, Papanastasiou A, Bakalopoulos N, Dietrich EM, Karachrysafi S, Toskas A, Mareti E, Morsi-Yeroyanni A, Sioga A. Papamitsou T, et al. Medicina (Kaunas). 2020 Jan 24;56(2):51. doi: 10.3390/medicina56020051. Medicina (Kaunas). 2020. PMID: 31991568 Free PMC article.

• Osteoporosis in postmenopausal women.

  Moe S, Paige A, Allan GM. Moe S, et al. Can Fam Physician. 2021 May;67(5):346. doi: 10.46747/cfp.6705346. Can Fam Physician. 2021. PMID: 33980628 Free PMC article. No abstract available.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon

• Other Literature Sources

  • scite Smart Citations

• Miscellaneous

  • NCI CPTAC Assay Portal